TEMPE, Ariz., Oct. 21, 2025 /PRNewswire/ GT Medical Technologies, a company focused on improving...
DAAdmin
2025 Brutal Biotech Investment Climate
Tucson, AZ – August 20, 2025 - Questex Fierce Biotech - shared by Reglagene, Inc. The first half...
Delta Development Team – Introducing BloodCOMM Premium
09/05/2025 - Introducing BloodCOMM Premium Built for organizations that demand the highest level...
Special Operations Forces Blood Cooler from Delta Development
09/03/2025 Delta Ice 2L debut at New Castle Blood Symposium Built for Special Operations Forces,...
UACI startup alumni Reglagene making impressive strides in brain cancer treatment
UACI Alumni Reglagene Advances Brain Cancer TreatmentUACI startup alumni Reglagene is making...
Reglagene RGN6024 Cover Story August 2025 Molecular Cancer Therapeutics
RGN6024 is the August 2025 Molecular Cancer Therapeutics cover storyReglagene's preclinical...
Calls for More Angel Investing
Ottawa, Ontario, Canada – April 30, 2025 - A recurring theme at the National Angel Capital...
Takes a Licking and Keeps on Ticking
04/21/2025 Delta Development Team APRU - Takes a Licking and Keeps on Ticking Even after four...
Be Patient as an Angel Investor
Early-stage founders struggle to put a price tag on their company when still early in development and commercialization.
The ‘why this is’ is revealed by identifying the solution.
First, we need to understand that capital markets are competitive. Interest rate “spreads” are the easiest way to understand risk vs. financial reward. When a U.S. Treasury bond (considered “safe”) pays 5%, then how much more needs to be paid for a riskier investment? For example, a home mortgage, inventory loan, or an investment in a pre-clinical oncology company?!
Ventura County firefighters make history with in-the-field blood transfusions
04/21/2025 Venture Count Firefighters Make History w/In the Field Blood Transfusions Alys Martinez...